References
- LawrenceRCFelsonDTHelmickCGNational Arthritis Data WorkgroupEstimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IIArthritis Rheum2008581263518163497
- BittonRThe economic burden of osteoarthritisAm J Manag Care200915Suppl 8S230S23519817509
- American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis Rheum20004391905191511014340
- JordanKMArdenNKDohertyMStanding Committee for International Clinical Studies Including Therapeutic Trials ESCISITEULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Ann Rheum Dis200362121145115514644851
- ZhangWMoskowitzRWNukiGOARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis Cartilage200816213716218279766
- TannenbaumHBombardierCDavisPRussellASThird Canadian Consensus Conference GroupAn evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus ConferenceJ Rheumatol200633114015716331802
- ChouRHelfandMPetersonKDanaTRobertsCComparative Effectiveness and Safety of Analgesics for Osteoarthritis. Comparative Effectiveness Review No. 4Rockville, MDAgency for Healthcare Research and Quality September Available from: http://www.effectivehealthcare.ahrq.gov/reports/final.cfmAccessed May 5, 2010
- National Collaborating Centre for Chronic ConditionsOsteoarthritis: National Clinical Guideline for Care and Management in AdultsLondon, UKRoyal College of Physicians2008 Available from: http://www.nice.org.uk/nicemedia/pdf/cg059fullguideline.pdfAccessed May 5, 2010
- RothSHNonsteroidal antiinflammatory drug gastropathy: we started it, why don’t we stop it?J Rheum20053271189119115996051
- AntmanEMBennettJSDaughertyAFurbergCRobertsHTaubertKAAmerican Heart AssociationUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
- Hippisley-CoxJCouplandCLoganRRisk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisBMJ200533175281310131616322018
- KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ200633275531302130816740558
- MamdaniMJuurlinkDNKoppANaglieGAustinPCLaupacisAGastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological studyBMJ200432874531415141615138157
- MooreRADerrySMcQuayHJCyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular riskBMC Musculoskelet Disord200787317683540
- HarirforooshSJamaliFRenal adverse effects of nonsteroidal anti-inflammatory drugsExpert Opin Drug Saf20098666968119832117
- MooreRADerrySMcQuayHJTopical agents in the treatment of rheumatic painRheum Dis Clin North Am200834241543218638684
- American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatric Soc200957813311346
- Voltaren Gel (diclofenac sodium topical gel) 1% Prescribing informationChadds Ford, PAEndo Pharmaceuticals Inc2009
- Pennsaid (diclofenac sodium topical solution) 1.5% w/w Prescribing informationHazelwood, MOMallinckrodt Inc2010
- HewittPGPobleteNWesterRCMaibachHIShainhouseJZIn vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimenPharm Res19981579889929688049
- WiechersJWThe barrier function of the skin in relation to percutaneous absorption of drugsPharm Weekbl Sci19891161851982694089
- WilliamsACBarryBWPenetration enhancersAdv Drug Deliv Rev200456560361815019749
- BookmanAAWilliamsKSShainhouseJZEffect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trialCMAJ2004171433333815313991
- RothSHShainhouseJZEfficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trialArch Intern Med2004164182017202315477437
- BaerPAThomasLMShainhouseZTreatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]BMC Musculoskelet Disord200564416086839
- SimonLSGriersonLMNaseerZBookmanAAZev ShainhouseJEfficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritisPain2009143323824519380203
- TugwellPSWellsGAShainhouseJZEquivalence study of a topical diclofenac solution (Pennsaid®) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trialJ Rheumatol200431102002201215468367
- AltmanRDHochbergMMurphyWAJWolfeELequesneMAtlas of individual radiographic features in osteoarthritisOsteoarthritis Cartilage19953Suppl A3708581752
- BellamyNKirwanJBoersMRecommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT IIIJ Rheumatol19972447998029101522
- AltmanRBrandtKHochbergMDesign and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshopOsteoarthritis Cartilage19964421724311048620
- Group for the Respect of Ethics and Excellence in Science (GREES): osteoarthritis sectionRecommendations for the registration of drugs used in the treatment of osteoarthritisAnn Rheum Dis19965585525578774185
- BellamyNCaretteSFordPMOsteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials – results of a consensus development (Delphi) exerciseJ Rheumatol19921934514571578462
- HuiXHewittPGPobleteNMaibachHIShainhouseJZWesterRCIn vivo bioavailability and metabolism of topical diclofenac lotion in human volunteersPharm Res19981510158915959794502
- KienzlerJLGoldMNollevauxFSystemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteersJ Clin Pharmacol2010501506119841157
- RochonPABinnsMALitnerJAAre randomized control trial outcomes influenced by the inclusion of a placebo group? A systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatmentJ Clin Epidemiol199952211312210201651
- ShainhouseJZGriersonLMNaseerZA long-term, open-label study to confirm the safety of topical diclofenac solution containing dimethyl sulfoxide in the treatment of the osteoarthritic kneeAm J Ther201017656657620216203
- RubinLFToxicologic update of dimethyl sulfoxideAnn N Y Acad Sci19834116106576723
- BrobynRDThe human toxicology of dimethyl sulfoxideAnn N Y Acad Sci19752434975061055563
- GarciaCAOcular toxicology of dimethyl sulfoxide and effects on retinitis pigmentosaAnn N Y Acad Sci198341148516349496
- ShirleyHHLunderganMKWilliamsHJSpruanceSLLack of ocular changes with dimethyl sulfoxide therapy of sclerodermaPharmacotherapy1989931651682755866
- TaylorHRMuñozBThe incidence and progression of lens opacitiesAust N Z J Ophthalmol19911943533561789977
- Italian-American Cataract Study GroupIncidence and progression of cortical, nuclear, and posterior subcapsular cataractsAm J Ophthalmol199411856236317977575
- LeskeMCChylackLTJrHeQIncidence and progression of cortical and posterior subcapsular opacities: the Longitudinal Study of Cataract. The LSC GroupOphthalmology199710412198719939400756
- LeskeMCChylackLTJrWuSYIncidence and progression of nuclear opacities in the Longitudinal Study of CataractOphthalmology199610357057128637678
- KleinBEKleinRLeeKEIncidence of age-related cataract: the Beaver Dam Eye StudyArch Ophthalmol199811622192259488275
- US Food and Drug AdministrationPublic Health Advisory – FDA announces important changes and additional warnings for COX-2 selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm150314.htmAccessed August 11, 2010